On March 8, 2023, the National Medical Products Administration (NMPA) of China conditionally approved Gumarontinib fo...
-
Scientists Establish integrative Proteogenomic and Pharmacological Landscape of Acute Myeloid Leukaemia in Chinese Population
Acute myeloid leukaemiais mainly characterized by an increase in myeloid cells in bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a five-...
-
Researchers Uncover Molecular Mechanisms of Lipid and Ligand Regulation in Prostaglandin Receptor DP2
In a study published in PNAS on December 12, a research team led by Eric H. Xu (XU Huaqiang) and WU Canrong from the Shanghai Institute of Materia Medica (SIMM) of the Chinese A...
-
Novel Nanovesicle May Improve Immunochemotherapy for TNBC
Interleukin 15 (IL15) is a key cytokine for promoting survival and proliferation of natural killer (NK) cells and CD8+ T cells. However, IL15 based supplementary therapies face ...